You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 8,906,938


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,906,938 protect, and when does it expire?

Patent 8,906,938 protects TAVNEOS and is included in one NDA.

This patent has sixty-four patent family members in thirty-four countries.

Summary for Patent: 8,906,938
Title:C5aR antagonists
Abstract: Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.
Inventor(s): Fan; Pingchen (Fremont, CA), Greenman; Kevin Lloyd (Sunnyvale, CA), Leleti; Manmohan Reddy (Sunnyvale, CA), Li; Yandong (San Jose, CA), Powers; Jay P. (Pacifica, CA), Tanaka; Hiroko (Foster City, CA), Yang; Ju (Cupertino, CA), Zeng; Yibin (Foster City, CA)
Assignee: ChemoCentryx, Inc. (Mountain View, CA)
Application Number:13/894,209
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 8,906,938

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Chemocentryx TAVNEOS avacopan CAPSULE;ORAL 214487-001 Oct 7, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,906,938

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2381778 ⤷  Sign Up 301166 Netherlands ⤷  Sign Up
European Patent Office 3508477 ⤷  Sign Up PA2022006 Lithuania ⤷  Sign Up
European Patent Office 2381778 ⤷  Sign Up 2022C/518 Belgium ⤷  Sign Up
European Patent Office 2381778 ⤷  Sign Up LUC00258 Luxembourg ⤷  Sign Up
European Patent Office 2381778 ⤷  Sign Up CA 2022 00022 Denmark ⤷  Sign Up
European Patent Office 2381778 ⤷  Sign Up 122022000029 Germany ⤷  Sign Up
European Patent Office 2381778 ⤷  Sign Up 17/2022 Austria ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.